Catalyst Wire Dossier Catalyst Wire Dossier

Intetumumab

intetumumab · Centocor, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Intetumumab, covering 2013-05-20 to 2013-08-19. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma [Phase 1, Phase 2]

See pricing